Three mothers, including one who had a high HbAL concentration could not be traced after delivery; all the other mothers had normal glucose tolerance at six weeks after delivery and all HbA1 concentrations had returned to normal at that time.
Discussion
As expected there was a higher proportion of obese mothers among those with big babies than in the control group. 4 There is a tendency for heavy babies to come from obese mothers or mothers with a high HbA, concentration but there is no statistically significant association between the two and only one patient with a high HbA, concentration was obese.
The 
Patients, methods, and results
Thirty outpatients with rheumatoid arthritis took part in a cross-over study to compare Seatone 300 mg with an identical placebo capsule three times daily. The placebo capsule consisted of dried fish and had an offensive smell indistinguishable from that of Seatone. Each treatment was given for four weeks and was added to the patients' existing drug regimen. The order of treatment was randomised and balanced. The patients were receiving various analgesic and anti-inflammatory drugs but these had been constant for at least four weeks before the start of the study and remained constant during the study. All patients had arthritis that was inadequately controlled by existing treatment, and all had requested a trial course of Seatone in response to an advertisement in the waiting area of the clinic.
Note was made at the start of the study and at the end of each treatment period of the pain score, using a visual analogue scale, duration of morning stiffness, articular index, proximal interphalangeal joint circumference, and analgesic requirements. Preference for one or other treatment period was measured at the end of the study, when side effects were recorded. The results were analysed using Student's t test applied to paired data, except for the duration of morning stiffness and preference, which were analysed using the Wilcoxon test. Twenty-six patients completed the study. The table summarises the results. There were no significant differences between Seatone and placebo in any measurement. Ten patients preferred Seatone, nine preferred placebo, and seven had no preference.
All the patients had requested Seatone treatment, so it is not surprising that several responded well. Thirteen out of 22 patients (59 %) with morning stiffness at the start of the study noted a substantial reduction in its duration, and in two cases it disappeared completely. Figures for the placebo group were identical. One patient was so enthusiastic about the first period of treatment that she returned her stick to the physiotherapy department; she Means 
Case report
The patient, a 59-year-old man, presented in 1980 complaining of excessive sweating of increasing severity for two years, which was most troublesome after meals and during the night. He also complained of intermittent diarrhoea for 10 years. This had been investigated in 1974 and no definite cause found. It had been adequately controlled with codeine phosphate. He had also noticed muscle weakness and fatigue for two years. He was completely blind as a result of glaucoma, for which he had been using "eye drops" since the age of 29 years. Apart from blindness no abnormal physical signs were apparent on examination. The following investigations were performed and yielded normal results: full blood count and erythrocyte sedimentation rate, blood urea and electrolyte concentrations, glucose tolerance test, thyroid function tests, urinary 4-hydroxy-3-methoxymandelic acid, gastrointestinal hormone assays (vasoactive intestinal polypeptide, pancreatic polypeptide, gastrin, and glucagon), and barium meal and followthrough. He was treated with propantheline with minimal improvement.
Two months later it was suggested he stop using pilocarpine, one of his eye drops. He had no ill effects from this and so took it on himself to stop using his other eye drops-namely, Phospholine iodide 0-25 % (ecothiopate). All his symptoms-the hyperhydrosis, muscle weakness, fatigue, and diarrhoea-resolved and he was able to stop taking the codeine phosphate. On reintroducing ecothiopate he noticed a return of postgustatory sweating; he stopped using these drops again and remained well and asymptomatic.
Comment
This case history emphasises the importance of a full drug history, including topical applications used, and full knowledge of the side effects of any such drugs. Such knowledge would have saved many years of symptoms and unnecessary investigations. Ecothiopate is an anticholinesterase, and symptoms of cholinergic overactivity have been reported., 2 These side effects may have potentially lethal implications in respect of surgery and anaesthesia, when muscle relaxants such as suxamethonium may be used. Gesztes3 reported prolonged apnoea occurring after anaesthesia in a patient who underwent laparotomy for abdominal colic, vomiting, and diarrhoea. The patient had been using ecothiopate eye drops for seven years before this event.
I would hope that the above case history was unusual. There is a problem, however, when patients are treated simultaneously by diverse specialist departments. Side effects of some specialist treatments simulate other medical disorders and may lead to referral to further specialised departments unfamiliar with both the treatment already being received and its potential side effects. 
Tetracycline-induced oesophageal ulceration
Oesophageal ulceration associated with ingestion of tablets is being increasingly recognised. Drugs already well known to be implicated are emepronium bromide and slow-release potassium." We report a case of oesophageal ulceration after ingestion of a tetracycline hydrochloride tablet.
Case report A previously fit 24-year-old Iraqi man with no history of upper gastrointestinal disease or oesophageal motility disorder was given a seven-day course of tablets containing 250 mg tetracycline hydrochloride for a chest infection. He was taking no other medication. On one occasion he swallowed a single tablet without water at 1 am, after which he went immediately to bed and slept. He was awakened at 4 am with severe epigastric and lower retrosternal pain unrelieved by water, milk, or antacids. He took no further tetracycline tablets and presented to the casualty department eight hours later still complaining of pain and odynophagia. Examination revealed only epigastric tenderness. He was referred to a medical outpatient clinic and seen two days later, by which time the epigastric pain had settled but odynophagia continued. There were no abnormal physical signs.
Investigations showed haemoglobin concentration to be 14-4 g/dl; a chest x-ray film was normal. Fibreoptic endoscopy revealed localised ulceration of the left lateral oesophageal wall 28 cm from the incisors. Oesophageal mucosa above and below this lesion was normal, as were the stomach and duodenum. Biopsy specimens of the ulcer showed pyogenic granulation tissue consistent with an inflammatory ulcer. No specific treatment was given and repeat endoscopy three weeks later showed the lesion to have healed without stricture formation.
Comment
Tetracycline hydrochloride tablets have been cited as a cause of oesophageal ulceration in two American cases,2 but both patients were young women and each had a hiatus hernia. No such hernia existed in our patient, but in all three cases the history was similar in that the offending tablet had been taken just before sleeping and the patient had awakened a few hours later with severe retrosternal pain.
